Pages that link to "Q50681098"
Jump to navigation
Jump to search
The following pages link to Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Aβ aggregation in the 5XFAD mouse model of Alzheimer's disease (Q50681098):
Displaying 50 items.
- MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease. (Q27327525) (← links)
- Spines, plasticity, and cognition in Alzheimer's model mice (Q27691328) (← links)
- Galantamine slows down plaque formation and behavioral decline in the 5XFAD mouse model of Alzheimer's disease (Q28540060) (← links)
- Activity-dependent p25 generation regulates synaptic plasticity and Aβ-induced cognitive impairment (Q28590111) (← links)
- Mechanisms underlying insulin deficiency-induced acceleration of β-amyloidosis in a mouse model of Alzheimer's disease (Q28731520) (← links)
- An anti-pyroglutamate-3 Aβ vaccine reduces plaques and improves cognition in APPswe/PS1ΔE9 mice (Q30316057) (← links)
- Beneficial effects of a pyrroloquinolinequinone-containing dietary formulation on motor deficiency, cognitive decline and mitochondrial dysfunction in a mouse model of Alzheimer's disease. (Q30358683) (← links)
- Glutaminyl cyclase-mediated toxicity of pyroglutamate-beta amyloid induces striatal neurodegeneration (Q30446186) (← links)
- APP transgenic mice for modelling behavioural and psychological symptoms of dementia (BPSD). (Q30455082) (← links)
- Identification of low molecular weight pyroglutamate A{beta} oligomers in Alzheimer disease: a novel tool for therapy and diagnosis (Q30497751) (← links)
- Rescue from excitotoxicity and axonal degeneration accompanied by age-dependent behavioral and neuroanatomical alterations in caspase-6-deficient mice (Q30512263) (← links)
- Pyroglutamate amyloid β (Aβ) aggravates behavioral deficits in transgenic amyloid mouse model for Alzheimer disease (Q30512697) (← links)
- Central CRF system perturbation in an Alzheimer's disease knockin mouse model. (Q30514236) (← links)
- Synaptic deficits in layer 5 neurons precede overt structural decay in 5xFAD mice (Q30582501) (← links)
- Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models. (Q30592224) (← links)
- Altered theta oscillations and aberrant cortical excitatory activity in the 5XFAD model of Alzheimer's disease (Q30640315) (← links)
- Eliminating microglia in Alzheimer's mice prevents neuronal loss without modulating amyloid-β pathology. (Q30805627) (← links)
- 1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer's Disease Mice (Q30853613) (← links)
- Focusing the amyloid cascade hypothesis on N-truncated Abeta peptides as drug targets against Alzheimer's disease (Q33624303) (← links)
- Phospho-eIF2α Level Is Important for Determining Abilities of BACE1 Reduction to Rescue Cholinergic Neurodegeneration and Memory Defects in 5XFAD Mice (Q33707706) (← links)
- Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice (Q33793048) (← links)
- Axonal degeneration in an Alzheimer mouse model is PS1 gene dose dependent and linked to intraneuronal Aβ accumulation (Q33814295) (← links)
- Early detection of cerebral glucose uptake changes in the 5XFAD mouse (Q33846922) (← links)
- Visible spectrum extended-focus optical coherence microscopy for label-free sub-cellular tomography (Q33901628) (← links)
- PERK mediates eIF2α phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer's disease (Q34024468) (← links)
- In vivo characterization of a bigenic fluorescent mouse model of Alzheimer's disease with neurodegeneration (Q34050850) (← links)
- Molecular Differences and Similarities Between Alzheimer's Disease and the 5XFAD Transgenic Mouse Model of Amyloidosis (Q34132850) (← links)
- Neuron loss in transgenic mouse models of Alzheimer's disease (Q34143614) (← links)
- Spine pruning in 5xFAD mice starts on basal dendrites of layer 5 pyramidal neurons (Q34147787) (← links)
- Differential spatio-temporal regulation of MMPs in the 5xFAD mouse model of Alzheimer's disease: evidence for a pro-amyloidogenic role of MT1-MMP. (Q34202064) (← links)
- Abnormal vibrissa-related behavior and loss of barrel field inhibitory neurons in 5xFAD transgenics. (Q34218993) (← links)
- Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease (Q34545200) (← links)
- Mechanisms of Alzheimer's Disease Pathogenesis and Prevention: The Brain, Neural Pathology, N-methyl-D-aspartate Receptors, Tau Protein and Other Risk Factors (Q34550307) (← links)
- Overexpression of Glutaminyl Cyclase, the Enzyme Responsible for Pyroglutamate Aβ Formation, Induces Behavioral Deficits, and Glutaminyl Cyclase Knock-out Rescues the Behavioral Phenotype in 5XFAD Mice (Q34575806) (← links)
- Neuroinflammation and neuronal loss precede Aβ plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease. (Q34656208) (← links)
- Area-specific alterations of synaptic plasticity in the 5XFAD mouse model of Alzheimer's disease: dissociation between somatosensory cortex and hippocampus (Q34999254) (← links)
- Deletion of the eIF2α Kinase GCN2 fails to rescue the memory decline associated with Alzheimer's disease (Q35023108) (← links)
- Activation of the nuclear receptor PPARδ is neuroprotective in a transgenic mouse model of Alzheimer's disease through inhibition of inflammation (Q35025065) (← links)
- Increased fragmentation of sleep-wake cycles in the 5XFAD mouse model of Alzheimer's disease (Q35182808) (← links)
- A combination Alzheimer's therapy targeting BACE1 and neprilysin in 5XFAD transgenic mice (Q35426661) (← links)
- Beneficial effects of the β-secretase inhibitor GRL-8234 in 5XFAD Alzheimer's transgenic mice lessen during disease progression (Q35551497) (← links)
- Pyroglutamate amyloid-β (Aβ): a hatchet man in Alzheimer disease (Q35604177) (← links)
- TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice (Q35753185) (← links)
- Genetic Deletion of the Clathrin Adaptor GGA3 Reduces Anxiety and Alters GABAergic Transmission (Q36021405) (← links)
- Effects of BACE1 haploinsufficiency on APP processing and Aβ concentrations in male and female 5XFAD Alzheimer mice at different disease stages (Q36113733) (← links)
- Rodent models for Alzheimer's disease drug discovery. (Q36117249) (← links)
- Alzheimer therapy with an antibody against N-terminal Abeta 4-X and pyroglutamate Abeta 3-X. (Q36340365) (← links)
- Neuron loss in the 5XFAD mouse model of Alzheimer's disease correlates with intraneuronal Aβ42 accumulation and Caspase-3 activation (Q36556213) (← links)
- Amyloid plaque pathogenesis in 5XFAD mouse spinal cord: retrograde transneuronal modulation after peripheral nerve injury (Q36586319) (← links)
- Comprehensive behavioral characterization of an APP/PS-1 double knock-in mouse model of Alzheimer's disease (Q36997908) (← links)